Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Pfizer's early bird Ibrance making the most of its head start, execs say
Pfizer's early bird Ibrance making the most of its head start, execs say
Pfizer's early bird Ibrance making the most of its head start, execs say
Submitted by
admin
on May 11, 2015 - 9:24am
Source:
Fierce Pharma Marketing
News Tags:
Pfizer
Ibrance
T-DM1. breast cancer
Headline:
Pfizer's early bird Ibrance making the most of its head start, execs say
Do Not Allow Advertisers to Use My Personal information
